Blog

Publicaciones

Testimonios

31 de octubre de 2025

¿Se puede mejorar la concentración y sociabilidad de niños con Espectro Autista?

Publicaciones

11 de diciembre de 2024

VidaStemCell Terapia Regenerativa con células madre – Dr. Jorge Tuma

Publicaciones

16 de octubre de 2024

RESCUE-HF Trial: Retrograde Delivery of Allogeneic Umbilical Cord Lining Subepithelial Cells in Patients With Heart Failure

Publicaciones

16 de octubre de 2024

Transcatheter Cardiovascular Therapeutics 2018 – Jorge Tuma

Publicaciones

16 de octubre de 2024

RESCUE-HF Trial: Retrograde Delivery of Allogeneic Umbilical CordLining Subepithelial Cells in Patients With Heart Failure – Jorge Tuma

Publicaciones

16 de octubre de 2024

Safety and feasibility of percutaneous retrogradecoronary sinus delivery of autologous bonemarrow mononuclear cell transplantation inpatients with chronic refractory angina – Jorge Tuma

Publicaciones

16 de octubre de 2024

AUTOLOGOUS BONE MARROW MONONUCLEAR CELL (ABMMC)TRANSPLANTATIONIN TYPE 1 AND TYPE 2 INSULIN DEPENDENT DIABETES MELLITUS (IDM) – Jorge Tuma

Publicaciones

16 de octubre de 2024

Diabetes and Cardiovascular Disease – Jorge Tuma

Publicaciones

16 de octubre de 2024

Redosing strategies for mesenchymal stem cell therapy for chronic obstructive pulmonary disease – Jorge Tuma

Publicaciones

16 de octubre de 2024

Heart Failure Improvement After Autologous Bone MarrowMononuclear Cells Transplantation – Jorge Tuma

Publicaciones

16 de octubre de 2024

LONG TERM BENEFIT OF AUTOLOGOUS BONEMARROW – Jorge Tuma

Publicaciones

15 de octubre de 2024

Optimized Mesenchymal Stem Cell Therapy for Chronic Obstructive Pulmonary Disease – Jorge Tuma

Publicaciones

14 de octubre de 2024

Five year follow-up of coronary sinus delivery of bone marrow cells for congestive heart failure

Publicaciones

13 de octubre de 2024

Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina – Jorge Tuma

Publicaciones

12 de octubre de 2024

Coronary Sinus Technique in End Stage Heart Failure. Jorge Tuma

Publicaciones

12 de octubre de 2024

Long Term Benefit Of Autologous Bone Marrow Transplantation By Retrograde Technique In Terminal Heart Failure (Liberty Study). – Jorge Tuma

Publicaciones

11 de octubre de 2024

Minimally invasive delivery of autologous bone marrow mononuclear cells transplantation in heart failure and refractory angina: three-year follow-up – Jorge Tuma

Publicaciones

10 de octubre de 2024

Cytotherapy 2008. Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells Transplantation in Parkinson disease. The First Clinical experience by Endovascular Therapy. Vol. 10, Supplement 1.

Publicaciones

10 de octubre de 2024

Cardiovascular Revascularization Medicine. Heart failure improvement by minimally invasive delivery of autologous bone marrow mononuclear cells transplantation.

Publicaciones

9 de octubre de 2024

Heart failure improvement by minimally invasive delivery of autologous bone marrow mononuclear cells transplantation. Long-term follow-up- Jorge Tuma

Publicaciones

8 de octubre de 2024

Successful treatment of refractory angina by minimally invasive delivery of autologous bone marrow mononuclear cells: long-term follow-up

Publicaciones

7 de octubre de 2024

Heart Failure Improvement after Autologous Bone Marrow Mononuclear Cells (ABMMC) Transplantation

Publicaciones

7 de octubre de 2024

Refractory angina treatment by percutaneous retrograde sinus technique transplantation of unselected autologous bone marrow mononuclear cells: long-term follow-up

Publicaciones

6 de octubre de 2024

Improvement of Stress LEVF rather Improvement of Stress LEVF rather than rest LEVF after Bone Marrow Cell Transplantation in Heart Failure Patients.

Publicaciones

5 de octubre de 2024

Autologous Mononuclear Bone Marrow Cell Transplantation in Type 1 and Type 2 Insulin Dependent Diabetes Mellitus.

Publicaciones

5 de octubre de 2024

Direct Pancreas Implant by Super Selective Catheterization of Spleen Artery of Autologous Bone Marrow Cells to Perform Type 2 Diabetes Patients

Publicaciones

3 de octubre de 2024

Biological Therapies – Jorge Tuma

Publicaciones

2 de octubre de 2024

Transcatheter Cardiovascular Therapeutics 2019

Publicaciones

Blog

Testimonios

Vida Stem Cell: Autismo – Mateo

Vida Stem Cell: Autismo – Waldo

Parálisis cerebral o encefalopatía hipóxica en niños

Parálisis cerebral o encefalopatía hipóxica en niños

Metananalisis Células Madre para Espectro Autista.

¿Se puede mejorar la concentración y sociabilidad de niños con Espectro Autista?

VidaStemCell Terapia Regenerativa con células madre – Dr. Jorge Tuma

RESCUE-HF Trial: Retrograde Delivery of Allogeneic Umbilical Cord Lining Subepithelial Cells in Patients With Heart Failure

Transcatheter Cardiovascular Therapeutics 2018 – Jorge Tuma

RESCUE-HF Trial: Retrograde Delivery of Allogeneic Umbilical CordLining Subepithelial Cells in Patients With Heart Failure – Jorge Tuma

Safety and feasibility of percutaneous retrogradecoronary sinus delivery of autologous bonemarrow mononuclear cell transplantation inpatients with chronic refractory angina – Jorge Tuma

AUTOLOGOUS BONE MARROW MONONUCLEAR CELL (ABMMC)TRANSPLANTATIONIN TYPE 1 AND TYPE 2 INSULIN DEPENDENT DIABETES MELLITUS (IDM) – Jorge Tuma

Diabetes and Cardiovascular Disease – Jorge Tuma

Redosing strategies for mesenchymal stem cell therapy for chronic obstructive pulmonary disease – Jorge Tuma

Heart Failure Improvement After Autologous Bone MarrowMononuclear Cells Transplantation – Jorge Tuma

LONG TERM BENEFIT OF AUTOLOGOUS BONEMARROW – Jorge Tuma

Optimized Mesenchymal Stem Cell Therapy for Chronic Obstructive Pulmonary Disease – Jorge Tuma

Five year follow-up of coronary sinus delivery of bone marrow cells for congestive heart failure

Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina – Jorge Tuma

Coronary Sinus Technique in End Stage Heart Failure. Jorge Tuma

Long Term Benefit Of Autologous Bone Marrow Transplantation By Retrograde Technique In Terminal Heart Failure (Liberty Study). – Jorge Tuma

Minimally invasive delivery of autologous bone marrow mononuclear cells transplantation in heart failure and refractory angina: three-year follow-up – Jorge Tuma

Cytotherapy 2008. Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells Transplantation in Parkinson disease. The First Clinical experience by Endovascular Therapy. Vol. 10, Supplement 1.

Cardiovascular Revascularization Medicine. Heart failure improvement by minimally invasive delivery of autologous bone marrow mononuclear cells transplantation.

Heart failure improvement by minimally invasive delivery of autologous bone marrow mononuclear cells transplantation. Long-term follow-up- Jorge Tuma

Successful treatment of refractory angina by minimally invasive delivery of autologous bone marrow mononuclear cells: long-term follow-up

Heart Failure Improvement after Autologous Bone Marrow Mononuclear Cells (ABMMC) Transplantation

Refractory angina treatment by percutaneous retrograde sinus technique transplantation of unselected autologous bone marrow mononuclear cells: long-term follow-up

Improvement of Stress LEVF rather Improvement of Stress LEVF rather than rest LEVF after Bone Marrow Cell Transplantation in Heart Failure Patients.

Autologous Mononuclear Bone Marrow Cell Transplantation in Type 1 and Type 2 Insulin Dependent Diabetes Mellitus.

Direct Pancreas Implant by Super Selective Catheterization of Spleen Artery of Autologous Bone Marrow Cells to Perform Type 2 Diabetes Patients

Biological Therapies – Jorge Tuma

Transcatheter Cardiovascular Therapeutics 2019

La medicina del futuro hoy. Aprovecha la oportunidad para darle un cambio a tu vida.

Torre 2 de Clínica San Felipe.
Av Gregorio Escobedo 676 Jesús María.

Solicita información

El doctor Jorge Tuma revisará su caso

Todos los derechos reservados. © 2024 VidaStemCell.

Blog

La medicina del futuro hoy. Aprovecha la oportunidad para darle un cambio a tu vida.

Torre 2 de Clínica San Felipe. Av Gregorio Escobedo 676 Jesús María.

Solicita información

El doctor Jorge Tuma revisará su caso

Todos los derechos reservados. © 2024 VidaStemCell.

Torre 2 de Clínica San Felipe.
Av Gregorio Escobedo 676 Jesús María.